Beta Bionics, Inc. (BBNX) Accumulated Expenses (2023 - 2026)

Beta Bionics (BBNX) has 4 years of Accumulated Expenses data on file, last reported at $17.3 million in Q1 2026.

• Quarterly Accumulated Expenses rose 64.02% year-over-year to $17.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.3 million (up 64.02% YoY) and the FY2025 annual result came in at $22.4 million, up 41.72% from the prior year.
• Accumulated Expenses fell to $17.3 million in Q1 2026 per BBNX's latest filing, from $22.4 million in the prior quarter.
• The five-year high for Accumulated Expenses was $22.4 million in Q4 2025, with the low at $8.1 million in Q4 2023.
• Average Accumulated Expenses over 4 years is $15.0 million, with a median of $15.8 million recorded in 2024.
• Year-over-year, Accumulated Expenses soared 94.73% in 2024 and soared 41.72% in 2025.
• Beta Bionics' Accumulated Expenses stood at $8.1 million in 2023, then soared by 94.73% to $15.8 million in 2024, then surged by 41.72% to $22.4 million in 2025, then retreated by 22.75% to $17.3 million in 2026.
• Business Quant data shows BBNX's Accumulated Expenses at $17.3 million in Q1 2026, $22.4 million in Q4 2025, and $17.6 million in Q3 2025.